Align Technology (NASDAQ:ALGN) Surprises With Q1 CY2026 Sales

April 30, 2026 - 00:51

Dental technology leader Align Technology (NASDAQ:ALGN) delivered a positive surprise for investors on Thursday, reporting first-quarter fiscal 2026 results that surpassed Wall Street’s revenue forecasts. The company, best known for its Invisalign clear aligner systems and iTero intraoral scanners, posted sales of $1.02 billion for the quarter ending March 31, 2026, marking a 6.2% increase compared to the same period last year.

Analysts had projected revenue of approximately $995 million, making the beat a notable achievement in a competitive dental market. The growth was driven by a 7.1% rise in Invisalign case volume, particularly in the Americas and the Asia-Pacific region, where adoption of digital orthodontics continues to accelerate. Align’s iTero scanner segment also contributed, with sales climbing 4.8% as dental practices increasingly invest in digital workflows.

“Our strong start to 2026 reflects the resilience of our business model and the growing demand for aesthetic, minimally invasive dental solutions,” said Align’s CEO in a prepared statement. The company also highlighted its expansion into emerging markets and the successful launch of new software features that streamline treatment planning for orthodontists.

Despite the upbeat revenue news, Align’s stock experienced modest volatility in after-hours trading, as some investors focused on slightly higher-than-expected operating expenses tied to research and development. The company maintained its full-year 2026 guidance, projecting continued mid-single-digit revenue growth. For the current quarter, Align expects sales between $1.03 billion and $1.05 billion, in line with market estimates. The results underscore Align’s ability to navigate economic headwinds while capitalizing on the long-term shift toward digital dentistry.